Setting the Standard Since 1971
Cart 0

Injectable Drug Compatibility News

IV Compatibility News - Winter 2022

Winter 2022 In this update we added a new monograph for TOCILIZUMAB. We also added new stability information to the monographs for DIGOXIN, HYDROMORPHONE HYDROCHLORIDE, MORPHINE HYDROCHLORIDE, SODIUM CHLORIDE, and VANCOMYCIN HYDROCHLORIDE. New compatibility information was added to the existing drug monograph for AMPHOTERICIN B, BUMETANIDE, FOSFOMYCIN DISODIUM, PLAZOMICIN, SCOPOLAMINE HYDROBROMIDE, and IMIPENEM, CILASTATIN AND RELEBACTAM with 28 other drugs.

Read more →


New IV Drug Compatibility & Stability Fall 2022

In this update we added a new monograph for MARGETUXIMAB-CMKB and METHYLPHENIDATE HYDROCHLORIDE. We also added new stability information to the monographs for CEFTOLOZANE AND TAZOBACTAM, CEFUROXIME SODIUM, FILGRASTIM, INSULIN ASPART, INSULIN GLULISINE, INSULIN LISPRO, LEVETIRACETAM, PIPERACILLIN AND TAZOBACTAM, and VANCOMYCIN HYDROCHLORIDE. New compatibility information was added to the existing drug monograph for IMIPENEM, CILASTATIN, and RELEBACTAM with 52 other drugs.

Read more →


New IV Drug Compatibility & Stability Summer 2022

In this update we added a new monograph for FOSDENOPTERIN HYDROBROMIDE. We also added new stability information to the monographs for DOBUTAMINE HYDROCHLORIDE, IRON DEXTRAN, and ZICONOTIDE. New compatibility information was added to the existing drug monograph for CEFIDEROCOL SULFATE TOSYLATE with 91 different parenteral drugs.

Read more →


New IV Compatibility & Stability Spring 2022

In this update we added a new monograph for CASIMERSEN. We also added new stability information for for AMPICILLIN SODIUM and INSULIN, REGULAR. New compatibility information was added to these existing drug monographs: MEROPENEM with 101 other drugs, TOTAL PARENTERAL NUTRITION SOLUTIONS, and VORICONAZOLE.

Read more →


New IV Drug Compatibility & Stability - Winter 2021

In this update we added new monographs for ATEZOLIZUMAB and TRILACICLIB. We also added new stability information to COVID-19 VACCINE, mRNA, and to 48 other existing drug monographs. New compatibility information was added to these existing drug monographs: CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, FENTANYL CITRATE, FOSPHENYTOIN, LEVETIRACETAM, NALOXONE HYDROCHLORIDE, NOREPINEPHRINE BITARTRATE, PIPERACILLIN AND TAZOBACTAM, PROPOFOL, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN. View Past Updates... Available for pre-order2022 Y-Site Compatibility Wall Charts This 27" x 27" poster is laminated and includes compatibility of 122 drugs and 4 infusion fluids updated with new data that has appeared in the complete KingĀ® Guide to...

Read more →